The Economics of the Health Care and the Pharmaceutical Industry

Kurt Richard Brekke, “Regulation, Generic Competition and Pharmaceutical Prices: Theory and Evidence from a Natural Experiment”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 2008.

Christopher P. Adams, “Spending on New Drug Development”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Emmanuelle Auriol, “Government Outsourcing: Public Contracting with Private Monopoly”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Andreea Balan Cohen, “Healthy, Wealthy and Wise? The Impact of the Old Age Assistance Program on Elderly Mortality in the United States?”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Francesca Barigozzi, “Endogenous Information and Self-Insurance in Insurance Markets: a Welfare Analysis”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Lieke Boonen, “Which Preferred Providers are really Preferred? Evidence of a Discrete Choice Experiment”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Andrew Ching, “The Effects of Detailing on Prescribing Decisions under Two-Sided Learning”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Paris Cleanthous, “Innovate or Imitate? Strategic Innovation Decision in the Pharmaceutical Industry”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Matthias Dahm, “The Economics of Investment in Clinical Trials”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Patricia Danzon, “Effects of Regulation on Drug Launch and Pricing in Interdependent Markets”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Claudia Desogus, “Strategic Pricing and Antitrust Issues in the European Pharmaceutical Market: the Glaxo Case”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Juan-Jose Ganuza, “R&D in the Pharmaceutical Industry: A World of Small Innovations”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Alessandro Gavazza, “Dynamic Inefficiencies in Employment-Based Health Insurance: Theory and Evidence”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Catarina Goulão, “Voluntary Social Insurance”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Simona Grassi, “Subsidy Design and Asymmetric Information: Wealth versus Benefits?”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Izabela Jelovac, “External Referencing and Pharmaceutical Price Negoatiation”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Sergi Jimenez-Martin, “The Determinants of Pricing in Pharmaceuticals: Are U.S. Prices really Higher than those of Canada?”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Natalia Jorgensen, “The Effect of Double Insurance Coverage on Prevention”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Karine Lamiraud, “The Impact of Information on Patient Preferences in Different Delivery Patterns: a Contingent Valuation Study of Prescription Versus OTC”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Xavier Martinez-Giralt, “On International Cost-Sharing of Pharmaceutical R&D”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Frank Müller-Langer, “Parallel Trade and the Pricing of Pharmaceutical Products”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Carmine Ornaghi, “Mergers and Innovation in Big Pharma”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Niklas Potrafke, “Public Health Expenditures in OECD Countries: Does Policy Matter?”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Fiona Scott Morton, “The Effect of Medicare Part D on Pharmaceutical Prices and Utilization”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.

Martin-Harry Vargas, “What is the Impact of Duplicate Coverage on the Demand for Health Care in Germany?”, The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, January 25–26, 2008.